Brooklyn ImmunoTherapeutics Inc (BTX)

5.87 +0.45  +8.30% NASDAQ Dec 7, 16:00 5.88 +0.01  +0.17% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All BTX News

News

View All Events

Events

Date Type Description
02/28/2022 Earnings Results Q4 2021 Earnings Results
11/09/2021 Earnings Results Q3 2021 Earnings Results
08/20/2021 09:00 EST AGM 2021 Annual General Meeting
08/16/2021 Earnings Results Q2 2021 Earnings Results
05/17/2021 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Brooklyn ImmunoTherapeutics Inc is a clinical stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells.
  • URL: https://www.brooklynitx.com
  • Investor Relations URL: N/A
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Feb. 28, 2022
  • Last Earnings Release: Nov. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.